In the subcutaneous xenograft model, ALDOA knockout in HepG2 cells and HCCLM3 cells significantly inhibited tumor size and tumor weight compared to the sgCtrl groups (Figs. 1E–G), similar to the effects in vitro. The gene discussed is ALDOA; the disease is neoplasm.